ARTICLE | Clinical News
ProAir HFA albuterol regulatory update
March 12, 2012 7:00 AM UTC
FDA approved a dose counter for use with Teva's ProAir HFA albuterol sulfate inhalation aerosol to treat or prevent bronchospasm with reversible obstructive airway disease and to prevent exercise-indu...